Position in JNJ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$553,167
+$82,150 QoQ
Shares Held
2,263
-0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026S&T Bank/PA holds $5,949,719 across 10 Drug Manufacturers - General names. JNJ ranks #2 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
21,548 | $4,686,474 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,263 | $553,167 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,564 | $188,133 | |
| 4 | LLY |
ELI LILLY & Co
|
200 | $183,953 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,916 | $116,204 | |
| 6 | AMGN |
Amgen Inc
|
299 | $105,202 | |
| 7 | NVO |
Novo Nordisk A S
|
1,430 | $52,552 | |
| 8 | PFE |
Pfizer Inc
|
1,314 | $36,896 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $553,167 | 2,263 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $471,017 | 2,276 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $396,056 | 2,136 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $245,774 | 1,609 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $260,866 | 1,573 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $234,718 | 1,623 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $241,307 | 1,489 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $229,763 | 1,572 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $258,482 | 1,634 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $256,113 | 1,634 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $257,454 | 1,653 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $290,983 | 1,758 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $272,490 | 1,758 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $684,341 | 3,874 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $633,182 | 3,876 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,306,650 | 7,361 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,348,011 | 7,606 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,312,448 | 7,672 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,239,028 | 7,672 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,264,214 | 7,674 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,230,817 | 7,489 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,194,356 | 7,589 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $438,302 | 2,944 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $460,562 | 3,275 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||